Judith L. Thijs

1.9k total citations
31 papers, 991 citations indexed

About

Judith L. Thijs is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Judith L. Thijs has authored 31 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Dermatology, 21 papers in Immunology and Allergy and 16 papers in Physiology. Recurrent topics in Judith L. Thijs's work include Dermatology and Skin Diseases (29 papers), Allergic Rhinitis and Sensitization (19 papers) and Asthma and respiratory diseases (16 papers). Judith L. Thijs is often cited by papers focused on Dermatology and Skin Diseases (29 papers), Allergic Rhinitis and Sensitization (19 papers) and Asthma and respiratory diseases (16 papers). Judith L. Thijs collaborates with scholars based in Netherlands, Germany and United Kingdom. Judith L. Thijs's co-authors include Marjolein de Bruin‐Weller, Daphne S. Bakker, Julia Drylewicz, DirkJan Hijnen, Femke van Wijk, Carla A.F.M. Bruijnzeel-Koomen, Stefan Nierkens, Jorien van der Schaft, Barbara Giovannone and Edward F. Knol and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Judith L. Thijs

29 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith L. Thijs Netherlands 16 854 667 379 159 155 31 991
Suzanne J. Tintle United States 11 592 0.7× 380 0.6× 216 0.6× 247 1.6× 131 0.8× 19 816
Daphne S. Bakker Netherlands 16 644 0.8× 472 0.7× 252 0.7× 117 0.7× 145 0.9× 33 721
Ilse C. Bihari Netherlands 12 533 0.6× 379 0.6× 218 0.6× 258 1.6× 93 0.6× 13 724
Juliane Rieker Germany 5 777 0.9× 448 0.7× 236 0.6× 365 2.3× 339 2.2× 9 1.1k
Margeaux Oliva United States 11 501 0.6× 326 0.5× 204 0.5× 143 0.9× 110 0.7× 17 650
Paola Facheris Italy 14 367 0.4× 190 0.3× 89 0.2× 151 0.9× 79 0.5× 36 489
Hirokazu Kinoshita Japan 9 306 0.4× 236 0.4× 157 0.4× 148 0.9× 39 0.3× 12 495
Laurence Pellerin United States 9 296 0.3× 237 0.4× 91 0.2× 147 0.9× 26 0.2× 10 538
Wojciech Francuzik Germany 14 178 0.2× 234 0.4× 79 0.2× 47 0.3× 88 0.6× 36 475
Ryoji Tanei Japan 12 321 0.4× 239 0.4× 100 0.3× 50 0.3× 51 0.3× 23 467

Countries citing papers authored by Judith L. Thijs

Since Specialization
Citations

This map shows the geographic impact of Judith L. Thijs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith L. Thijs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith L. Thijs more than expected).

Fields of papers citing papers by Judith L. Thijs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith L. Thijs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith L. Thijs. The network helps show where Judith L. Thijs may publish in the future.

Co-authorship network of co-authors of Judith L. Thijs

This figure shows the co-authorship network connecting the top 25 collaborators of Judith L. Thijs. A scholar is included among the top collaborators of Judith L. Thijs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith L. Thijs. Judith L. Thijs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2024). Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy. Clinical & Experimental Allergy. 54(4). 241–252. 8 indexed citations
2.
Stölzl, Dora, Lotte S. Spekhorst, Edward F. Knol, et al.. (2024). Type 2 Immune‐Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients. Clinical & Experimental Allergy. 55(1). 97–99.
3.
Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2023). High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease. Clinical and Translational Allergy. 13(1). e12221–e12221. 8 indexed citations
4.
Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2023). Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis. Allergy. 78(8). 2266–2276. 15 indexed citations
5.
Spekhorst, Lotte S., Daphne S. Bakker, Julia Drylewicz, et al.. (2022). Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis. Allergy. 77(11). 3398–3407. 31 indexed citations
6.
Spekhorst, Lotte S., Marlies de Graaf, Floris C. Loeff, et al.. (2022). Association of Serum Dupilumab Levels at 16 Weeks With Treatment Response and Adverse Effects in Patients With Atopic Dermatitis. JAMA Dermatology. 158(12). 1409–1409. 10 indexed citations
7.
Luijk, Chantal van, Daphne S. Bakker, Lotte S. Spekhorst, et al.. (2022). Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.. PubMed. 102. adv00666–adv00666. 7 indexed citations
8.
Luijk, Chantal van, Daphne S. Bakker, Lotte S. Spekhorst, et al.. (2022). Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis. Acta Dermato Venereologica. 102. adv00666–adv00666. 13 indexed citations
9.
Bakker, Daphne S., Marlot van der Wal, Barbara Giovannone, et al.. (2021). Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis. Journal of Investigative Dermatology. 141(8). 1943–1953.e13. 53 indexed citations
10.
Angiolilli, Chiara, Emmerik F A Leijten, Cornelis P. J. Bekker, et al.. (2021). ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal Fibroblasts. Journal of Investigative Dermatology. 142(2). 402–413. 24 indexed citations
11.
Bakker, Daphne S., Marlies de Graaf, Stefan Nierkens, et al.. (2021). Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters. Journal of Allergy and Clinical Immunology. 149(1). 125–134. 27 indexed citations
12.
Bakker, Daphne S., Lieneke F.M. Ariëns, Amanda Lans, et al.. (2020). Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis. The Journal of Allergy and Clinical Immunology In Practice. 9(3). 1389–1392.e2. 31 indexed citations
13.
Ariëns, Lieneke F.M., Jorien van der Schaft, Lotte S. Spekhorst, et al.. (2020). Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry. Journal of the American Academy of Dermatology. 84(4). 1000–1009. 63 indexed citations
14.
Bakker, Daphne S., Lieneke F.M. Ariëns, Barbara Giovannone, et al.. (2020). EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers. Allergy. 75(12). 3287–3289. 16 indexed citations
15.
Schaft, Jorien van der, Judith L. Thijs, F.M. Garritsen, Deepak M.W. Balak, & Marjolein de Bruin‐Weller. (2019). Towards personalized treatment in atopic dermatitis. Expert Opinion on Biological Therapy. 19(5). 469–476. 14 indexed citations
16.
Bakker, Daphne S., Julia Drylewicz, Stefan Nierkens, et al.. (2019). 418 Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment. Journal of Investigative Dermatology. 139(9). S286–S286. 1 indexed citations
17.
Thijs, Judith L., Ian Strickland, Carla A.F.M. Bruijnzeel-Koomen, et al.. (2017). Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis. Journal of Allergy and Clinical Immunology. 140(3). 730–737. 119 indexed citations
18.
Thijs, Judith L., Marjolein de Bruin‐Weller, & DirkJan Hijnen. (2016). Current and Future Biomarkers in Atopic Dermatitis. Immunology and Allergy Clinics of North America. 37(1). 51–61. 26 indexed citations
19.
Gordon, Nathaniel C., Ian Strickland, Richard May, et al.. (2015). Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13. Chemistry & Biology. 22(11). 1442–1452. 12 indexed citations
20.
Thijs, Judith L., Todor K. Krastev, Stephan Weidinger, et al.. (2015). Biomarkers for atopic dermatitis. Current Opinion in Allergy and Clinical Immunology. 15(5). 453–460. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026